Andrey Doronichev, CEO, OPTIC | Onyx Live | JPM 2026
Автор: Onyx
Загружено: 2026-02-16
Просмотров: 38
Описание:
Big pharma often plays “fund, license, kill”...
a strategy which requires extreme precision in an industry where missing a competitor or hallucinating a patent number is a never-event.
OPTIC is building an agentic AI platform for biopharma that:
ingests everything that matters, from FDA filings and patents to internal strategy documents
maps competitive landscapes, evaluates assets, and informs both regulatory and commercial decisions
uses a multi-agent system designed to avoid hallucination
The result: decisions delivered ~10× faster and ~5× cheaper than traditional approaches.
Onyx caught up with CEO Andrey Doronichev at JPM 2026 to find out more.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
